← Evidence map

ArticleThe New England journal of medicine2016

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

Hans-Henrik Parving et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

NCT0639897770 enrolled2024
Full record →Abstract, authors, funding and every citing paper · PMID 28106974